Toxikon
- Company typePublic
- Founded1976
- HeadquartersBedford, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
Toxikon firmographics
Firmographics- Name
- Toxikon
- Legal name
- Laboratory Corporation of America Holdings
- Website
- https://toxikon.com
- Company type
- Public
- Founded year
- 1976
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Toxikon industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Testing Laboratories and Services (541380)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN)
- akta.pro secondary industry
- Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
Keywords
Where Toxikon is headquartered
LocationHeadquarters
- HQ city
- Bedford
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Toxikon business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Revenue model
- Clinical Laboratory Testing: Diagnostic testing services for patients through physician orders, hospital systems, and direct consumer access. Services include routine labwork, specialty testing, genetic testing, and disease-specific diagnostics across multiple therapeutic areas including oncology, neurology, rheumatology, and women's health.
- Biopharma Services: Comprehensive drug development services including nonclinical development, central laboratory services, early phase development, regulatory consulting, and commercialization support for pharmaceutical companies worldwide.
- Labcorp OnDemand: Direct-to-consumer at-home testing kits and patient service center testing available without physician order. Includes over 50 self-ordered lab tests for wellness monitoring, with subscription options for certain offerings.
- Employer & Organization Services: Workplace drug testing, employee wellness programs, biometric screenings, health coaching, and population health management services for employers and organizations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Labcorp OnDemand - Individual Tests |
| Subscription | Monthly | Labcorp OnDemand - Subscriptions |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
Toxikon product offering
Product offeringCore offering
Toxikon is a preclinical contract research organization delivering product development services from concept to final product. The firm conducts safety, toxicology, and efficacy studies to support pharmaceutical, biotechnology, and medical device developers in advancing their products through preclinical stages of development.
Differentiator
Problem solved
Functional benefit
Brands
- Labcorp OnDemand: Self-ordered lab testing service allowing patients to access 50+ tests, including at-home kits and tests at patient service centers
- MyLabcorp
- Labcorp Diagnostic Assistant
- Labcorp Link
- Labcorp Venture Fund
- Ovia Health
- Labcorp OnDemand
Products and services
- Preclinical Product Development Services
Quantifiable outcome
- Over 85% of new drugs and therapeutic products approved by the U.S. FDA were supported by Labcorp
- +1 more outcomes
Companies that use Toxikon
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles2 records
Toxikon technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Toxikon partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Amazon Web Services (AWS)coreAWS provides cloud infrastructure for Labcorp's AI-powered real-world data platform for Alzheimer's disease, developed in partnership to deliver longitudinal laboratory data at scale with advanced analytics.
- DatavantcoreDatavant partners with Labcorp to enable the AI-powered real-world data platform, providing data connectivity capabilities for longitudinal patient data analysis.
- WalgreenscoreHundreds of Walgreens pharmacy locations offer Labcorp sample collection services, providing convenient retail access points for patients.
- InvitaecoreLabcorp acquired Invitae, a genetic testing company, welcoming the Invitae team as scientific leaders in the development and adoption of genetic testing.
- Ovia HealthminorPartnership for women's health resources including pregnancy, fertility, parenting, and menopause apps integrated with Labcorp testing services.
Scale indicators5 records
Recent moves2 records
Expansion highlights3 records
Toxikon competitors and assessment
Company assessmentBroad incumbents
- PPD (Thermo Fisher Scientific): PPD, now part of Thermo Fisher Scientific, is a top-five global CRO with preclinical, clinical, and laboratory services. Comparable to Toxikon as a scaled full-service CRO competitor for biopharma development programs.
- IQVIA: IQVIA is the largest global CRO with broad preclinical, clinical, and real-world data capabilities. Relevant as a large incumbent that bids for the same end-to-end biopharma development contracts that can include Toxikon's preclinical scope.
- Labcorp Drug Development: Labcorp Drug Development is the broader CRO arm of Toxikon's parent, offering early-phase clinical development, central lab, and bioanalytical services. As Toxikon's own parent business, it bundles Toxikon's preclinical capabilities into integrated offerings spanning preclinical through clinical.
- ICON plc: ICON is a top-tier global CRO offering preclinical through Phase IV services, including laboratory and bioanalytical capabilities. Comparable to Toxikon at the preclinical end of ICON's full-service portfolio, often competing for the same biopharma clients.
Direct peers
- WuXi AppTec: WuXi AppTec operates a large preclinical and toxicology service line within its broader CRO platform. Highly comparable to Toxikon on preclinical study design, DMPK, and IND-enabling work, with significant global biotech client overlap.
- Charles River Laboratories: Charles River is the largest dedicated preclinical CRO globally, offering toxicology, DMPK, and safety assessment services directly comparable to Toxikon's core IND-enabling offerings. The closest direct competitor for outsourced preclinical study awards.
- Eurofins Scientific: Eurofins is a global contract laboratory group with significant preclinical, toxicology, and product-safety testing capabilities serving pharma, chemical, and consumer-products clients. Directly comparable to Toxikon's preclinical product safety testing scope.
- Intertek: Intertek provides contract laboratory and product testing services across pharma, chemical, and consumer-products industries. Overlaps with Toxikon on regulated safety/toxicology testing for product development programs.
- SGS SA: SGS is a global testing, inspection, and certification company with a life sciences CRO arm offering preclinical safety and product testing. Directly comparable to Toxikon on regulated product safety and contract laboratory services.
Regional players
- Pace Analytical Services: Pace Analytical is a U.S.-focused contract laboratory providing life sciences, environmental, and product safety testing. Comparable to Toxikon on regulated product safety testing, with primary U.S. geographic overlap.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Toxikon social profiles
Digital presenceToxikon financial estimates
Financial estimateRevenue estimate
Valuation estimate
Toxikon leadership team
Management profileNumber of profiles
Profiles2 records
Toxikon subsidiaries and ownership
Company hierarchySubsidiaries22 records
Toxikon funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Toxikon M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Toxikon
What does Toxikon do?
Toxikon is a preclinical contract research organization delivering product development services from concept to final product. The firm conducts safety, toxicology, and efficacy studies to support pharmaceutical, biotechnology, and medical device developers in advancing their products through preclinical stages of development.
Is Toxikon a public or private company?
Toxikon is a public company. It is classified as corporate owned and is currently operating.
When was Toxikon founded?
Toxikon was founded in 1976. It employs 101 to 250 people.
Where is Toxikon based?
Toxikon is headquartered in Bedford, United States, in the North America region.
How does Toxikon make money?
Four revenue lines are on record. Clinical Laboratory Testing is the primary driver. The others are biopharma Services, labcorp OnDemand and employer & Organization Services.
Who are Toxikon's main competitors?
Broad incumbents on record are PPD (Thermo Fisher Scientific), IQVIA, Labcorp Drug Development and ICON plc. Direct peers are WuXi AppTec, Charles River Laboratories, Eurofins Scientific, Intertek and SGS SA. Pace Analytical Services is listed as a regional player.
Does Toxikon have an API?
No public API is recorded for Toxikon.
What industry is Toxikon in?
Toxikon's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAFAN, Nonclinical Study Management & Regulatory Writing (IND-enabling), with a secondary code of HLAGAKAL, Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control). Its NAICS code is 541380 and its SIC code is 8731.